TABLE 8.
CTs (in duplicate) obtained by testing of simulated samples containing both CMV and EBV with the Invitrogen Platinum Quantitative PCR SuperMix-UDG kita
| CMV componenta |
CT for CMV or EBV with the indicated CMV component and the following EBV componenta:
|
|||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| EBV 1 (20.58)
|
EBV 2 (23.25)
|
EBV 3 (26.08)
|
EBV 4 (29.84)
|
EBV 5 (>40)
|
||||||
| CMV | EBV | CMV | EBV | CMV | EBV | CMV | EBV | CMV | EBV | |
| CMV 1 (21.56) | 20.96 | 20.33 | 21.71 | 22.81 | 21.52 | 25.58 | 21.38 | 29.18/>40 | 21.62 | >40 |
| CMV 2 (24.00) | 23.60 | 20.42 | 23.75 | 23.20 | 24.06 | 25.83 | 23.98 | 28.51 | 23.20 | >40 |
| CMV 3 (27.62) | 26.74 | 20.36 | 26.96 | 23.18 | 27.03 | 26.24 | 27.30 | 28.68 | 26.73 | >40 |
| CMV 4 (31.06) | >40 | 20.32 | 29.54/>40 | 23.24 | 31.19 | 26.22 | 30.85 | 28.97 | 30.30 | >40 |
| CMV 5 (>40) | >40 | 20.30 | >40 | 23.22 | >40 | 26.32 | >40 | 29.98 | >40 | >40 |
a
The number(s) in parentheses after each CMV or EBV component of the simulated sample is the CT obtained for that component by the singleplex CMV or EBV assay, respectively.